Evidence map›Paper›PMID 26088833›Full record

ArticlePrenatal diagnosis2015

Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing.

J Helgeson, J Wardrop, T Boomer, E Almasri, W B Paxton, J S Saldivar, N Dharajiya, T J Monroe, D H Farkas, D S Grosu and 1 more

Abstract read
In one paragraph

Article in Prenatal diagnosis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletion in a large clinical cohort.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2021
    Article
  12. Utility of noninvasive genome-wide screening: a prospective cohort of obstetric patients undergoing diagnostic testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  13. Article
  14. Review
  15. Impact of Emerging Technologies in Prenatal Genetic Counseling.Cold Spring Harbor perspectives in medicine · 2020
    Review
  16. Genome-wide noninvasive prenatal screening for carriers of balanced reciprocal translocations.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

J HelgesonSequenom Laboratories, San Diego, CA, USA.
J WardropSequenom Laboratories, San Diego, CA, USA.
T BoomerSequenom Laboratories, San Diego, CA, USA.
E AlmasriSequenom Laboratories, San Diego, CA, USA.
W B PaxtonSequenom Laboratories, San Diego, CA, USA.
J S SaldivarSequenom Laboratories, San Diego, CA, USA.
N DharajiyaSequenom Laboratories, San Diego, CA, USA.
T J MonroeSequenom Laboratories, Morrisville, NC, USA.
D H FarkasSequenom Laboratories, Grand Rapids, MI, USA.
D S GrosuSequenom Laboratories, San Diego, CA, USA.
R M McCulloughSequenom Laboratories, San Diego, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA novel algorithm to identify fetal microdeletion events in maternal plasma has been developed and used in clinical laboratory-based noninvasive prenatal testing. We used this approach to identify the subchromosomal events 5pdel, 22q11del, 15qdel, 1p36del, 4pdel, 11qdel, and 8qdel in routine testing. We describe the clinical outcomes of those samples identified with these subchromosomal events.

methodsBlood samples from high-risk pregnant women submitted for noninvasive prenatal testing were analyzed using low coverage whole genome massively parallel sequencing. Sequencing data were analyzed using a novel algorithm to detect trisomies and microdeletions.

resultsIn testing 175,393 samples, 55 subchromosomal deletions were reported. The overall positive predictive value for each subchromosomal aberration ranged from 60% to 100% for cases with diagnostic and clinical follow-up information. The total false positive rate was 0.0017% for confirmed false positives results; false negative rate and sensitivity were not conclusively determined.

conclusionNoninvasive testing can be expanded into the detection of subchromosomal copy number variations, while maintaining overall high test specificity. In the current setting, our results demonstrate high positive predictive values for testing of rare subchromosomal deletions.

Indexed as

Gene DeletionGenome, HumanMaternal Serum Screening TestsFemaleHumansPregnancy

Identifiers

PMID26088833
PMCPMC5034801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.